Bhargavee Gnanasambandam is addressing the persistent incidence of cervical cancer in medically underserved areas by proposing a 15-minute antibody-based cervical cancer device. This innovative solution allows women to self-collect samples, providing immediate results and intervention, thus overcoming the discomfort and delays associated with the current invasive pelvic exam and waiting period for results.

Further Activities to have a look at